Literature DB >> 35230463

Another trial for the TARGET trial.

Mohammad H Alshaer1,2, Charles A Peloquin3,4.   

Abstract

Entities:  

Year:  2022        PMID: 35230463     DOI: 10.1007/s00134-022-06654-9

Source DB:  PubMed          Journal:  Intensive Care Med        ISSN: 0342-4642            Impact factor:   41.787


× No keyword cloud information.
  2 in total

1.  Using Machine Learning To Define the Impact of Beta-Lactam Early and Cumulative Target Attainment on Outcomes in Intensive Care Unit Patients with Hospital-Acquired and Ventilator-Associated Pneumonia.

Authors:  Mohammad H Alshaer; Nicole Maranchick; Chen Bai; Kelly L Maguigan; Bethany Shoulders; Timothy W Felton; Sumith K Mathew; Mamoun T Mardini; Charles A Peloquin
Journal:  Antimicrob Agents Chemother       Date:  2022-06-14       Impact factor: 5.938

2.  Another trial for the TARGET trial. Author's reply.

Authors:  Stefan Hagel; Mathias W Pletz; Thomas Lehmann
Journal:  Intensive Care Med       Date:  2022-03-23       Impact factor: 41.787

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.